NEW YORK — In his presentation at OSN New York 2019, Uday Devgan, MD, demonstrates the insertion of the Juvene accommodating IOL (LensGen) and discusses its success rate. An FDA trial for the lens is expected to begin in early 2020.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2020 Healio All Rights Reserved.